2-(Tributylstannyl)thiazole
Product Information
Molecular Formula
C15H29NSSn
Molecular Weight
374.17
Description
Reagent for arylation of thiazole by Stille cross-coupling.
Synonyms
2-(Tributylstannyl)-1,3-thiazole; tributyl(1,3-thiazol-2-yl)stannane; Tributyl-2-thiazolylstannane; tributylstannylthiazole; Thiazole,2-(tributylstannyl)-; 2-(TRIBUTYLSTANNYL)-; tributyl-2-thiazolyltin; 2-(Tributyltin)thiazole; (2-thiazolyl)tributyltin; 2-tributylstannyl-thiazol; thiazol-2-yl tributyltin; tributyl(2-thiazolyl)tin; 2-tributylstannyl thiazole; 2-tributylstannyl-thiazole; 2-tributylstannanylthiazole; 2-tributylstannanyl thiazole; 2-Tributylstannyl(thiazole); 2-tri-n-butylstannylthiazole; tri-n-butyl(2-thiazolyl)tin; 2-(tributylstannanyl)thiazole; 2-(tributylstannyl) thiazole; tri-n-butyl-thiazol-2-yl tin
IUPAC Name
tributyl(1,3-thiazol-2-yl)stannane
SMILES
CCCC[Sn](CCCC)(CCCC)C1=NC=CS1
InChI
InChI=1S/3C4H9.C3H2NS.Sn/c3*1-3-4-21-2-5-3-4-1/h3*1,3-4H2,2H31-2H
InChI Key
WUOFQGMXQCSPPV-LMBSCFLOAM
Boiling Point
307-309 °C (lit.)
Flash Point
230.0 °F - closed cup
Purity
94%
Density
1.1900 g/mL at 25 °C (lit.)
Refractive Index
n20/D 1.5200 (lit.)
Safety Information
Hazards
H301 - H312 - H315 - H319 - H372 - H400
Precautionary Statement
P273 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P305 + P351 + P338 - P314
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
10
Exact Mass
375.104274 g/mol
Monoisotopic Mass
375.104274 g/mol
Topological Polar Surface Area
41.1Ų
Heavy Atom Count
18
Formal Charge
0
Complexity
189
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-114058224-A | Photo-thermal response super-hydrophobic anti-icing composite coating and preparation method thereof | 2021-11-29 |
| WO-2022017371-A1 | Heterocyclic compound having dual inhibitor activity of phosphatidylinositol 3-kinase δ and γ and medical use thereof | 2020-07-21 |
| WO-2021262684-A1 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | 2020-06-22 |
| WO-2021195781-A1 | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use | 2020-04-01 |
| WO-2021195782-A1 | Methods of using myt1 inhibitors | 2020-04-01 |
| WO-2021190727-A1 | Compounds and their use in the treatment of bacterial infection | 2020-03-24 |
| WO-2021188938-A1 | Phd inhibitor compounds, compositions, and use | 2020-03-20 |
| WO-2021188944-A1 | Phd inhibitor compounds, compositions, and their use | 2020-03-20 |
| WO-2021178488-A1 | Eif4e inhibitors and uses thereof | 2020-03-03 |
| KR-102303750-B1 | Thiazole derivative, manufacturing method for same, thiazole polymer and manufacturing method for same | 2020-02-26 |
